Jessika Richards1, Molly Wascher2, Michael Alwan3, James Beardsley4, Ryan Naseman5, Todd Nesbit2, Tate Trujillo6, Patrick Fuller7. 1. Ascension St. John Hospital, Detroit, MI, USA. 2. The Johns Hopkins Hospital, Baltimore, MD, USA. 3. Northwest Hospital & Medical Center-UW Medicine, Seattle, WA, USA. 4. Wake Forest Baptist Health, Winston-Salem, NC, USA. 5. UK HealthCare, Lexington, KY, USA. 6. Indiana University Health, Indianapolis, IN, USA. 7. Nebraska Medicine, Omaha, NE, USA.
Abstract
Purpose: The process of privileging pharmacists is an important step in developing optimal pharmacy practice models. Currently, little published literature exists detailing the status of pharmacist privileging efforts. The objective of this study is to assess and characterize a snapshot of the current and future state of privileging practices in pharmacy at Vizient academic medical centers (AMCs) and their affiliate institutions. Methods: An electronic survey questionnaire was sent to Vizient pharmacy directors and their affiliates to assess institutional privileging practices and identify perceived or actual barriers. The survey was divided into 2 pathways based on the current status of privileging at the institution. Results: In total, 46 directors of pharmacy completed the survey. Only 33% (15/46) of pharmacy directors indicated they had a current privileging process in place. About 70% (21/30) of institutions without an established privileging process indicated they were considering establishing a process. For institutions without an established privileging process, most pharmacy directors identified a lack of organizational support and resources as barriers to implementation. Conclusion: Although credentialing and privileging is considered a national priority to aid in expanding and enhancing pharmacists' scope of practice, our survey demonstrated that few respondents currently have a privileging process in place. The results from this study may highlight important barriers and keys to success to be considered when implementing a privileging process.
Purpose: The process of privileging pharmacists is an important step in developing optimal pharmacy practice models. Currently, little published literature exists detailing the status of pharmacist privileging efforts. The objective of this study is to assess and characterize a snapshot of the current and future state of privileging practices in pharmacy at Vizient academic medical centers (AMCs) and their affiliate institutions. Methods: An electronic survey questionnaire was sent to Vizient pharmacy directors and their affiliates to assess institutional privileging practices and identify perceived or actual barriers. The survey was divided into 2 pathways based on the current status of privileging at the institution. Results: In total, 46 directors of pharmacy completed the survey. Only 33% (15/46) of pharmacy directors indicated they had a current privileging process in place. About 70% (21/30) of institutions without an established privileging process indicated they were considering establishing a process. For institutions without an established privileging process, most pharmacy directors identified a lack of organizational support and resources as barriers to implementation. Conclusion: Although credentialing and privileging is considered a national priority to aid in expanding and enhancing pharmacists' scope of practice, our survey demonstrated that few respondents currently have a privileging process in place. The results from this study may highlight important barriers and keys to success to be considered when implementing a privileging process.
Authors: Ezekiel Emanuel; Neera Tanden; Stuart Altman; Scott Armstrong; Donald Berwick; François de Brantes; Maura Calsyn; Michael Chernew; John Colmers; David Cutler; Tom Daschle; Paul Egerman; Bob Kocher; Arnold Milstein; Emily Oshima Lee; John D Podesta; Uwe Reinhardt; Meredith Rosenthal; Joshua Sharfstein; Stephen Shortell; Andrew Stern; Peter R Orszag; Topher Spiro Journal: N Engl J Med Date: 2012-08-01 Impact factor: 91.245
Authors: Trisha A Jordan; Joel A Hennenfent; John J Lewin; Todd W Nesbit; Robert Weber Journal: Am J Health Syst Pharm Date: 2016-07-13 Impact factor: 2.637
Authors: Joseph J Saseen; Toni L Ripley; Deborah Bondi; John M Burke; Lawrence J Cohen; Sarah McBane; Karen J McConnell; Bryan Sackey; Cynthia Sanoski; Anahit Simonyan; Jodi Taylor; Joseph P Vande Griend Journal: Pharmacotherapy Date: 2017-05-02 Impact factor: 4.705